Chain, Connor
Sheehan, Joseph P.
Xu, Xincheng
Ghaffari, Soodabeh http://orcid.org/0000-0002-9782-7930
Godbole, Aneesh
Kim, Hahn
Freundlich, Joel S.
Rabinowitz, Joshua D. http://orcid.org/0000-0002-1247-4727
Gitai, Zemer http://orcid.org/0000-0002-3280-6178
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI-CCSG P30CA072720-5921)
Article History
Received: 17 October 2023
Accepted: 6 March 2024
First Online: 9 April 2024
Competing interests
: A patent application (PCT/US2023/076235 Princeton, NJ, 2023) for the use of Fluorofolin as an antibiotic is currently pending. Z.G. is a co-founder and has equity interest from Arrepath. The remaining authors declare no competing interests.